Circulating levels of testosterone, sex hormone binding globulin and colorectal cancer risk: Observational and mendelian randomization analyses

Niki Dimou, Nagisa Mori, Sophia Harlid, Justin Harbs, Richard M. Martin, Karl Smith-Byrne, Nikos Papadimitriou, D. Timothy Bishop, Graham Casey, Sandra M. Colorado-Yohar, Michelle Cotterchio, Amanda J. Cross, Loic Le Marchand, Yi Lin, Kenneth Offit, N. Charlotte Onland-Moret, Ulrike Peters, John D. Potter, Thomas E. Rohan, Elisabete WeiderpassMarc J. Gunter, Neil Murphy

Research output: Contribution to journalArticlepeer-review

Abstract

Background: Epidemiologic studies evaluating associations between sex steroid hormones and colorectal cancer risk have yielded inconsistent results. To elucidate the role of circulating levels of testosterone, and sex hormone-binding globulin (SHBG) in colorectal cancer risk, we conducted observational and Mendelian randomization (MR) analyses. Methods: The observational analyses included 333,530 participants enrolled in the UK Biobank with testosterone and SHBG measured. HRs and 95% confidence intervals (CI) were estimated using multivariable Cox proportional hazards models. For MR analyses, genetic variants robustly associated with hormone levels were identified and their association with colorectal cancer (42,866 cases/42,752 controls) was examined using two-sample MR. Results: In the observational analysis, there was little evidence that circulating levels of total testosterone were associated with colorectal cancer risk; the MR analyses showed a greater risk for women (OR per 1-SD = 1.09; 95% CI, 1.01-1.17), although pleiotropy may have biased this result. Higher SHBG concentrations were associated with greater colorectal cancer risk for women (HR per 1-SD = 1.16; 95% CI, 1.05-1.29), but was unsupported by the MR analysis. There was little evidence of associations between free testosterone and colorectal cancer in observational andMRanalyses. Conclusions: Circulating concentrations of sex hormones are unlikely to be causally associated with colorectal cancer. Additional experimental studies are required to better understand the possible role of androgens in colorectal cancer development.

Original languageEnglish (US)
Pages (from-to)1336-1348
Number of pages13
JournalCancer Epidemiology Biomarkers and Prevention
Volume30
Issue number7
DOIs
StatePublished - Jul 2021

ASJC Scopus subject areas

  • Epidemiology
  • Oncology

Fingerprint

Dive into the research topics of 'Circulating levels of testosterone, sex hormone binding globulin and colorectal cancer risk: Observational and mendelian randomization analyses'. Together they form a unique fingerprint.

Cite this